US Patent Issued to BRAINTALE on April 7 for "Method for determination of an indicator representative of a change in the brain of an individual caused by a demyelinating or related disease, affecting the state of the myelin of the brain" (French Inventor)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,593,981, issued on April 7, was assigned to BRAINTALE (Strasbourg, France).

"Method for determination of an indicator representative of a change in the brain of an individual caused by a demyelinating or related disease, affecting the state of the myelin of the brain" was invented by Vincent Perlbarg (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for determination of an indicator representative of a change in the brain caused by a demyelinating disease, the method including, for each region of interest of the brain, determining a regional coefficient of one of the following diffusion coefficients: the radial diffusion, the axial diffusio...